When Li et al[42] studied the progression of steatosis and the molecular mechanism of NASH, they found that miR-145a-5p could down-regulate NR4A2, inhibit the expression of NASH-related genes, and reduce the progression of liver inflammation, liver injury, and fibrosis. Here, NR4A2 is linked to metabolic dysfunction-associated steatohepatitis.